September 30, 2016 8:28 AM ET

Pharmaceuticals

Company Overview of APT Pharmaceuticals, Inc.

Company Overview

APT Pharmaceuticals, Inc. develops cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. The company's cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.

700 Airport Boulevard

Suite 350

Burlingame, CA 94010

United States

Founded in 1999

Phone:

650-931-1666

Fax:

650-931-1667

Key Executives for APT Pharmaceuticals, Inc.

Chief Operating Officer
Age: 65
Global Head of Regulatory Affairs and Executive Vice President of Development Europe
Age: 58
Chief Technology Officer
Age: 56
Senior Director of Project Management
Vice President of Pulmonary Transplant Program
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact APT Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.